Work

Adjuvant immune checkpoint inhibitor therapy after curative-intent resection or ablation for high-risk hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.

Year: 2026

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e16289

Authors: Hasan Daher, Saba Daher, Hamza Altal, Amira Eftaiha, Ban Al-Goran, Sakshi Singal

Institutions: Jordan University of Science and Technology, East Tennessee State University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162682007

FWCI:

Cites:

Cited by:

Related to: